ポイント・オブ・ケア検査の世界市場:グルコース監視キット、心血管代謝監視キット、感染症検査キット、凝集モニタリングキット、腫瘍マーカー

◆英語タイトル:Point-of-Care Diagnostics Market by Products (Glucose, Cardiometabolic Monitoring, & Infectious Disease Testing Kits, Cardiac & Tumor Markers), End Users (Home, Hospitals, Ambulatory Care), Over-the- Counter & Prescription Based - Global Forecast to 2021
◆商品コード:MAM-MD-2702
◆発行会社(調査会社):MarketsandMarkets
◆発行日:2016年7月7日
◆ページ数:222
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD5,650 ⇒換算¥627,150見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥738,150見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥904,650見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、ポイント・オブ・ケア検査の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、市場環境分析、製品別分析、需要先別分析、地域別分析、市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
【レポートの概要】

The global point-of-care (POC) diagnostics market is expected to reach USD 36.96 Billion by 2021 from USD 23.16 Billion in 2016, growing at a CAGR of 9.8% between 2016 and 2021.
On the basis of products, the point-of-care diagnostics market is divided into 12 segments, namely, glucose monitoring kits, infectious diseases testing kits, cardiometabolic monitoring kits, coagulation monitoring kits, hematology testing kits, urinalysis testing kits, cholesterol test strips, drugs-of-abuse testing kits, tumor/cancer markers, pregnancy and fertility testing kits, fecal occult testing kits, and other products. The infectious diseases testing kits segment is expected to grow at the highest CAGR in the next five years, owing to the increasing number of HIV-infected individuals across the globe coupled with increasing availability and awareness about infectious disease POC testing. The glucose monitoring kits segment holds the largest share of the market across the globe. The rising diagnosis of diabetes, ongoing technological advancements in devices used for self-monitoring blood glucose level, and growing patient awareness towards POC testing are the key factors contributing to the growth of this market segment. Moreover, the low cost of test strips and development of novel test strips are other factors contributing to the growth of the glucose monitoring kits market, globally.

On the basis of mode of prescription, the global market is divided into two segments, namely, prescription-based testing kits and over-the-counter testing kits. Prescription-based testing kits segment holds the largest share in the market, owing to rising incidence and prevalence of lifestyle diseases and lack of awareness on over the counter POCT devices.

The global point-of-care diagnostics market is also segmented into three categories on the basis of end users–professional diagnostic centers (hospitals, outpatient healthcare settings, and ambulatory care settings), research laboratories, and home care.

On the basis of geography, this market is classified into four regions, namely, North America (U.S. and Canada), Europe (Germany, France, U.K., and Rest of Europe), Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific), and Rest of the World. In 2016, the global point-of-care diagnostics market is estimated to be dominated by North America. A number of factors such as the growing prevalence of lifestyle diseases, increasing number of product approvals, and rising government initiatives for developing novel products in this region are driving the growth of the North American market. The Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021. Factors such as growing initiatives by market players to expand their distribution network, increasing patient population base, and rising number of partnerships and joint ventures among POC providers are propelling the growth of the Asia-Pacific market.

New product launch is the primary growth strategy adopted by major players to expand their product portfolio in the global point-of-care diagnostics market. Moreover, strategies such as product approvals; partnerships, agreements, and collaborations; and acquisitions were also adopted by a significant number of market players to expand their presence and increase their visibility in the market.

Abbott Laboratories, Inc. (U.S.),Roche Diagnostics Limited (Switzerland), Siemens AG (Germany), Beckman Coulter, Inc. (U.S.),Becton, Dickinson and Company (U.S.), Johnson & Johnson (U.S.), Alere Inc. (U.S.), Instrumentation Laboratory (U.S.), PTS Diagnostics (U.S.), and Nova Biomedical (U.S.) are some of the key players operating in the global point-of-care diagnostics market.

【レポートの目次】

1 Introduction (Page No. – 18)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.4 Markets Covered
1.4.1 Years Considered for the Study
1.5 Currency
1.6 Limitations
1.7 Stakeholders

2 Research Methodology (Page No. – 23)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation Methodology
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Research Design
2.4 Market Data Validation and Triangulation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 32)
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights (Page No. – 37)
4.1 Market Overview
4.2 Geographic Analysis: Market Growth Rate, By Product (2016–2021)
4.3 Geographic Analysis: Market Size, By Mode of Prescription, 2016 vs 2021
4.4 Market, By End User and Region, 2016 (USD Million)

5 Market Overview (Page No. – 41)
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 High Prevalence of Infectious Diseases in Developing Countries
5.3.1.2 Increasing Incidence of Lifestyle Diseases
5.3.1.3 Rising Usage of Home-Based POC Devices
5.3.1.4 Growing Government Support
5.3.1.5 Private Investments and Venture Capital Activities
5.3.1.6 Technological Advancements and New Product Launches
5.3.1.7 Growing Number of Regulatory Approvals for Novel Immunoassay Techniques
5.3.1.8 Shortage of Skilled Laboratory Technicians Increasing Preference of POC Testing
5.3.1.9 Rising Number of Clia-Waived POC Tests
5.3.2 Restraints
5.3.2.1 Product Recalls
5.3.2.2 Pricing Pressures Owing to Reimbursement Cuts and Budget Constraints Hampering Profits
5.3.2.3 Stringent and Time-Consuming Regulatory Policies are Significantly Increasing Gestation Period for Product Launches
5.3.3 Opportunities
5.3.3.1 Emerging Markets (India, China, and Brazil) to Pave New Growth Avenues
5.3.3.2 Healthcare Decentralization—Converting Lab Tests to POC Tests
5.3.3.3 Increasing Number of Conferences and Events
5.3.3.4 Miniaturization of POC Testing Devices
5.3.3.5 POC Tests With Multiplexing Capabilities
5.3.4 Challenges
5.3.4.1 Lack of Alignment With Definitive Central Lab Methods
5.3.4.2 Disadvantages of POC Testing Over Central Lab Methods
5.3.4.3 Inadequate Knowledge About Use of POC Devices in Professional Settings
5.3.4.4 Reluctance Towards Changing Existing Treatment Practices
5.3.5 Burning Issues
5.3.5.1 Unfavorable Reimbursement Limiting the Adoption of POC Tests
5.3.5.2 High Cost of Devices—A Prime Concern
5.3.5.3 Negative Public Perception Related to POC Tests

6 Industry Trends (Page No. – 58)
6.1 Introduction
6.2 Industry Trends
6.2.1 Standardization of POC Testing Devices
6.2.2 Acquisition of Small Players
6.2.3 Growing Focus on Microfluidics-Based POC Devices
6.2.3.1 Microfluidics-Based Loc Devices Will Bring Laboratory Testing to the Patient’s Fingertips
6.2.3.2 Evolution of Paper-Based Microfluidic POC Diagnostic Devices
6.3 Pricing and Cost Analysis
6.4 Porter’s Five Forces Analysis
6.4.1 Threat From New Entrants
6.4.2 Threat of Substitutes
6.4.3 Bargaining Power of Suppliers
6.4.4 Bargaining Power of Buyers
6.4.5 Intensity of Competitive Rivalry
6.5 Strategic Benchmarking
6.5.1 Technology Integration & New Product Launches
6.5.2 Incorporation of Wireless Technology in POC Devices

7 Point-Of-Care Diagnostics Market, By Product (Page No. – 68)
7.1 Introduction
7.2 Glucose Monitoring Kits
7.3 Cardiometabolic Monitoring Kits
7.3.1 Cardiac Markers
7.3.2 Blood Gas/Electrolytes Testing Kits
7.3.3 HBA1C Testing Kits
7.3.4 LIPID Testing Kits
7.4 Infectious Disease Testing Kits
7.4.1 Influenza Testing Kits
7.4.2 HIV Testing Kits
7.4.3 Hepatitis C Testing Kits
7.4.4 Sexually Transmitted Diseases (STDs) Testing Kits
7.4.5 Tropical Diseases Testing Kits
7.4.6 Healthcare-Associated Infection Testing Kits
7.4.7 Respiratory Infections Testing Kits
7.4.8 Other Infectious Disease Testing Kits
7.5 Coagulation Monitoring Kits
7.5.1 PT/INR Testing Kits
7.5.2 Activated Clotting Time (ACT/APTT) Testing Kits
7.6 Pregnancy and Fertility Testing Kits
7.6.1 Pregnancy Testing Kits
7.6.2 Fertility Testing Kits
7.7 Tumor/Cancer Markers
7.8 Urinalysis Testing Kits
7.9 Cholesterol Test Strips
7.10 Hematology Testing Kits
7.11 Drugs-Of-Abuse Testing Kits
7.12 Fecal Occult Testing Kits
7.13 Other POC Testing Kits

8 Point-Of-Care Diagnostics Market, By Prescription Mode (Page No. – 109)
8.1 Introduction
8.2 Prescription-Based Testing Kits
8.3 OTC Testing Kits Market

9 Point-Of-Care Diagnostics Market, By End User (Page No. – 115)
9.1 Introduction
9.2 Professional Diagnostic Centers
9.2.1 Hospitals/Critical Care Settings
9.2.2 Outpatient Healthcare Settings
9.2.3 Ambulatory Care Settings
9.3 Research Laboratories
9.4 Home Care
9.5 Others

10 Point-Of-Care Diagnostics Market, By Region (Page No. – 124)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.1.1 Growing Prevalence of Lifestyle Diseases and Rising Geriatric Population
10.2.1.2 Increasing Government and Venture Capital Funding
10.2.1.3 Growing Number of Product Approvals Using Clia Waiver
10.2.1.4 Nih Support for the Development of POC Testing Devices
10.2.1.5 Slow Inflow of Multi-Analyte POC Devices
10.2.2 Canada
10.2.2.1 Expanding Patient Population Base
10.2.2.2 Increasing Focus of Players on the Canadian Market
10.2.2.3 Increasing Government Initiatives
10.2.2.4 Lack of Reimbursement and Awareness
10.3 Europe
10.3.1 Germany
10.3.1.1 Increasing Number of Conferences
10.3.1.2 Ongoing Development of Novel Products
10.3.1.3 Rising Incidence of Diabetes and Cancer in Germany
10.3.1.4 Low Reimbursement Affecting Market Growth in the Country
10.3.2 France
10.3.2.1 Increasing Reimbursement for Point-Of-Care Tests
10.3.2.2 High Prevalence of Diabetes in France
10.3.3 U.K.
10.3.3.1 Growing Number of New Product Launches
10.3.3.2 Increasing Government Support for POCt Devices
10.3.3.3 Budget Constraints Hampering Market Growth
10.3.4 Rest of Europe (RoE)
10.4 Asia-Pacific
10.4.1 Japan
10.4.1.1 Growing Initiatives By Market Players
10.4.1.2 Increasing Demand for Rapid Flu Tests in Japan
10.4.1.3 Centralized Healthcare Delivery System
10.4.2 China
10.4.2.1 Increasing Partnerships and Joint Ventures Fueling Market Growth
10.4.2.2 Increasing Support From Government and Private Companies
10.4.2.3 Poor Reimbursement and Time-Consuming Product Registration Procedure
10.4.3 India
10.4.3.1 Increasing Prevalence of Target Diseases
10.4.3.2 Growing Government Initiatives
10.4.3.3 Conferences
10.4.3.4 Lack of Reimbursement and Insurance Coverage Hampering Market Growth
10.4.4 Rest of Asia-Pacific
10.5 Rest of the World (RoW)
10.5.1 Increasing Patient Population in Africa
10.5.2 Huge Patient Base for Respiratory Diseases
10.5.3 Growing Initiatives By Market Players

11 Competitive Landscape (Page No. – 168)
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Situation and Trends
11.3.1 New Product Launches,Product Enhancements, and Product Approvals
11.3.2 Agreements, Partnerships, and Collaborations
11.3.3 Product Showcase and Product Recall
11.3.4 Acquisitions
11.3.5 Other Strategies

12 Company Profiles (Page No. – 175)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 Introduction
12.2 Roche Diagnostics Limited (A Subsidiary of F. Hoffmann-La Roche Ltd.)
12.3 Abbott Laboratories, Inc.
12.4 Siemens AG
12.5 Alere Inc.
12.6 Johnson & Johnson
12.7 Instrumentation Laboratory (A Werfen Company)
12.8 Nova Biomedical
12.9 Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation)
12.10 Becton, Dickinson and Company
12.11 PTs Diagnostics

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 207)
13.1 Discussion Guide
13.2 Other Developments
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports

List of Tables (94 Tables)

Table 1 Point-Of-Care Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 2 Point-of-Care Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 3 Glucose Monitoring Kits Market Size, By Region, 2014–2021 (USD Million)
Table 4 Cardiometabolic Monitoring Kits Market Size, By Type, 2014–2021 (USD Million)
Table 5 Cardiometabolic Monitoring Kits Market Size, By Region, 2014–2021 (USD Million)
Table 6 Cardiac Markers Market Size, By Region, 2014–2021 (USD Million)
Table 7 Blood Gas/Electrolytes Market Size, By Region, 2014–2021 (USD Million)
Table 8 HBA1C Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 9 LIPID Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 10 Infectious Disease Testing Kits Market Size, By Type, 2014–2021 (USD Million)
Table 11 Infectious Disease Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 12 Influenza Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 13 HIV Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 14 Hepatitis C Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 15 STD Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 16 Tropical Diseases Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 17 Healthcare-Associated Infection Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 18 Respiratory Infections Testing Kits Market Size, By Region, 2014–-2021 (USD Million)
Table 19 Other Infectious Disease Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 20 Coagulation Monitoring Kits Market Size, By Type, 2014–2021 (USD Million)
Table 21 Coagulation Monitoring Kits Market Size, By Region, 2014–2021 (USD Million)
Table 22 PT/INR Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 23 ACT/APTT Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 24 Pregnancy and Fertility Testing Kits Market Size, By Type, 2014–2021 (USD Million)
Table 25 Pregnancy and Fertility Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 26 Pregnancy Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 27 Fertility Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 28 Tumor/Cancer Markers Market Size, By Region, 2014–2021 (USD Million)
Table 29 Urinalysis Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 30 Cholesterol Test Strips Market Size, By Region, 2014–2021 (USD Million)
Table 31 Hematology Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 32 Drugs-Of-Abuse Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 33 Fecal Occult Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 34 Other POC Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 35 Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 36 Prescription-Based Testing Kits Market Size, By Region, 2014-2021 (USD Million)
Table 37 OTC Testing Kits Market Size, By Region, 2014-2021 (USD Million)
Table 38 Market Size, By End User, 2014-2021 (USD Million)
Table 39 Professional Diagnostic Centers Market Size, By Type, 2014-2021 (USD Million)
Table 40 Professional Diagnostic Centers Market Size, By Region, 2014-2021 (USD Million)
Table 41 Research Laboratories Market Size, By Region, 2014-2021 (USD Million)
Table 42 Home Care Point-of-Care Diagnostics Market Size, By Region, 2014-2021 (USD Million)
Table 43 Other End Users Point-of-Care Diagnostics Market Size, By Region, 2014-2021 (USD Million)
Table 44 Point-of-Care Diagnostics Market Size, By Region, 2014-2021 (USD Million)
Table 45 North America: Point-of-Care Diagnostics Market Size, By Country, 2014-2021 (USD Million)
Table 46 North America: Point-of-Care Diagnostics Market Size, By Product, 2014-2021 (USD Million)
Table 47 North America: Point-of-Care Diagnostics Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 48 North America: Point-of-Care Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 49 U.S.: Point-of-Care Diagnostics Market Size, By Product, 2014-2021 (USD Million)
Table 50 U.S.: Point-of-Care Diagnostics Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 51 U.S.: Point-of-Care Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 52 Canada: Point-of-Care Diagnostics Market Size, By Product, 2014-2021 (USD Million)
Table 53 Canada: Point-of-Care Diagnostics Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 54 Canada: Point-of-Care Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 55 Europe: Point-of-Care Diagnostics Market Size, By Country, 2014-2021 (USD Million)
Table 56 Europe: Point-of-Care Diagnostics Market Size, By Product, 2014-2021 (USD Million)
Table 57 Europe: Point-of-Care Diagnostics Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 58 Europe: Point-of-Care Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 59 Germany: Point-of-Care Diagnostics Market Size, By Product, 2014-2021 (USD Million)
Table 60 Germany: Point-of-Care Diagnostics Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 61 Germany: Point-of-Care Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 62 France: Point-of-Care Diagnostics Market Size, By Product, 2014-2021 (USD Million)
Table 63 France: Point-of-Care Diagnostics Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 64 France: Market Size, By End User, 2014-2021 (USD Million)
Table 65 U.K.: Market Size, By Product, 2014-2021 (USD Million)
Table 66 U.K.: Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 67 U.K.: Market Size, By End User, 2014-2021 (USD Million)
Table 68 RoE: Market Size, By Product, 2014-2021 (USD Million)
Table 69 RoE: Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 70 RoE: Market Size, By End User, 2014-2021 (USD Million)
Table 71 APAC: Market Size, By Country, 2014-2021 (USD Million)
Table 72 APAC: Market Size, By Product, 2014-2021 (USD Million)
Table 73 APAC: Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 74 APAC: Market Size, By End User, 2014-2021 (USD Million)
Table 75 Japan: Market Size, By Product, 2014-2021 (USD Million)
Table 76 Japan: Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 77 Japan: Market Size, By End User, 2014-2021 (USD Million)
Table 78 China: Market Size, By Product, 2014-2021 (USD Million)
Table 79 China: Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 80 China: Market Size, By End User, 2014-2021 (USD Million)
Table 81 India: Market Size, By Product, 2014-2021 (USD Million)
Table 82 India: Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 83 India: Market Size, By End User, 2014-2021 (USD Million)
Table 84 RoAPAC: Market Size, By Product, 2014-2021 (USD Million)
Table 85 RoAPAC: Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 86 RoAPAC: Market Size, By End User, 2014-2021 (USD Million)
Table 87 RoW: Market Size, By Product, 2014-2021 (USD Million)
Table 88 RoW: Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 89 RoW: Market Size, By End User, 2014-2021 (USD Million)
Table 90 Top 5 New Product Launches, Product Enhancements, and Product Approvals, 2015 & 2016
Table 91 Top 5 Agreements, Partnerships, and Collaborations, 2015 & 2016
Table 92 Product Showcase and Product Recall, 2013 & 2014
Table 93 Acquisitions, 2013 & 2014
Table 94 Top 5 Other Strategies, 2013–2015

List of Figures (55 Figures)

Figure 1 Global Point-Of-Care Diagnostics Market: Research Methodology Steps
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Data Triangulation Methodology
Figure 4 Global Market, By Product, 2016 (USD Million)
Figure 5 Global Market, By Product, 2016 vs 2021
Figure 6 Global Market, By Prescription Mode, 2016 vs 2021
Figure 7 Global Market, By Region, 2016-2021 (USD Million)
Figure 8 Increasing Prevalence of Infectious and Lifestyle Diseases is Driving Growth in the Market
Figure 9 The Infectious Disease Testing Kits Segment in the Asia-Pacific Region to Offer Lucrative Growth Opportunities for Market Players
Figure 10 Prescription-Based Testing Kits Segment to Dominate the Market in 2016
Figure 11 Professional Diagnostic Centers to Dominate the Global Market in 2016
Figure 12 POC Diagnostics Market Segmentation
Figure 13 POC Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 14 Global Number HIV Patients, 2014 (Million)
Figure 15 Incidence Rate of TB in Developing Nations, 2014
Figure 16 Estimated Number of Diabetic Patients, By Region, 2015 vs 2040
Figure 17 Healthcare Decentralization Across Prominent Countries, 2013
Figure 18 Pricing Trend (2013-2018): Twofold Decline Expected in the Price of POC Devices in APAC as Compared to North America
Figure 19 Porter’s Five Forces Analysis (2016): Low Capital Requirement Increasing Competition in the Industry
Figure 20 Strategic Benchmarking: Roche and Abbott Largely Focus on Technological Integration and Product Enhancement
Figure 21 Strategic Benchmarking: Alere and Abbott Largely Adopt Strategies for Product Enhancement
Figure 22 The Infectious Disease Testing Kits Segment is Projected to Grow at the Highest CAGR During the Forecast Period
Figure 23 North America is Expected to Dominate the Global Point-Of-Care Diagnostics Market in 2016
Figure 24 North America is Expected to Dominate the Global Glucose Monitoring Kits Market in 2016
Figure 25 The Blood Gas/Electrolytes Segment to Witness Highest Growth in the Global Cardiometabolic Monitoring Kits Market During the Forecast Period
Figure 26 Asia-Pacific to Witness Highest Growth in the Global Cardiometabolic Monitoring Kits Market During the Forecast Period
Figure 27 North America is Expected to Dominate the Global Blood Gas/Electrolytes Market in 2016
Figure 28 Hepatitis C Testing Kits Segment to Witness Highest Growth in the Global Infectious Disease Testing Kits Market During the Forecast Period
Figure 29 North America is Expected to Dominate the Global Infectious Diseases Testing Kits Market in 2016
Figure 30 Asia-Pacific to Witness Highest Growth in the Global Hepatitis C Testing Kits Market in 2016
Figure 31 Asia-Pacific to Witness Highest Growth in the Global Hai Testing Kits Market in 2016
Figure 32 North America is Expected to Dominate the Global Pregnancy & Fertility Testing Kits Market in 2016
Figure 33 North America is Expected to Dominate the Global Hematology Testing Kits Market in 2016
Figure 34 Asia-Pacific to Witness Highest Growth in the Global Fecal Occult Testing Kits Market During the Forecast Period
Figure 35 OTC Testing Kits Segment to Witness Highest Growth During the Forecast Period
Figure 36 North America to Dominate the Prescription-Based Testing Kits Market in 2016
Figure 37 Asia-Pacific to Witness Highest Growth in the OTC Testing Kits Segment
Figure 38 Broad End-User Base for Point-Of-Care Testing Kits
Figure 39 Home Care End-User Segment to Witness Highest Growth During the Forecast Period
Figure 40 North America to Dominate the Professional Diagnostic Centers Market in 2016
Figure 41 Asia-Pacific to Witness Highest Growth During the Forecast Period
Figure 42 Point-Of-Care Diagnostics Market: Growth Forecast, By Region (2016–2021)
Figure 43 North America: Point-Of-Care Diagnostics Market Snapshot
Figure 44 Europe: Point-Of-Care Diagnostics Market Snapshot
Figure 45 APAC: Point-Of-Care Diagnostics Market Snapshot
Figure 46 Global Point-Of-Care Diagnostics Market Share Analysis, By Key Player, 2015
Figure 47 Battle for Market Share: New Product Launches, Product Enhancements, and Product Approvals–Key Growth Strategy Adopted Between 2013 & 2016
Figure 48 Geographic Revenue Snapshot (2015)
Figure 49 Roche Diagnostics Limited: Company Snapshot
Figure 50 Abbott Laboratories, Inc.: Company Snapshot
Figure 51 Siemens AG: Company Snapshot
Figure 52 Alere Inc.: Company Snapshot
Figure 53 Johnson & Johnson: Company Snapshot
Figure 54 Danaher Corporation: Company Snapshot
Figure 55 Becton, Dickinson and Company: Company Snapshot

【レポートのキーワード】

ポイント・オブ・ケア検査、POC診断、POC検査装置、グルコース監視キット、心血管代謝監視キット、感染症検査キット、凝集モニタリングキット、腫瘍マーカー検査、医療機器、妊娠検査キット、検尿、病院、家庭

★調査レポート[ポイント・オブ・ケア検査の世界市場:グルコース監視キット、心血管代謝監視キット、感染症検査キット、凝集モニタリングキット、腫瘍マーカー]販売に関する免責事項
★調査レポート[ポイント・オブ・ケア検査の世界市場:グルコース監視キット、心血管代謝監視キット、感染症検査キット、凝集モニタリングキット、腫瘍マーカー]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆